MicroRNA in late lung development and bronchopulmonary dysplasia: the need to demonstrate causality
about
The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia.MicroRNA-142 is a multifaceted regulator in organogenesis, homeostasis, and disease.Looking ahead: where to next for animal models of bronchopulmonary dysplasia?The need for coordination of research activities in pediatric lung diseases.Stereological analysis of individual lung lobes during normal and aberrant mouse lung alveolarisation.Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia.Can We Understand the Pathobiology of Bronchopulmonary Dysplasia?Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia.Neonatal exposure to hyperoxia leads to persistent disturbances in pulmonary histone signatures associated with NOS3 and STAT3 in a mouse model.Transmission of microRNA antimiRs to mouse offspring via the maternal-placental-fetal unit.Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants.Recommended Reading from the University of Colorado Fellows.
P2860
Q33711647-7CBF15F8-51ED-4A27-AD85-3E615EDC3DEEQ37644435-E813220A-F2D4-4150-97DE-C99EF22DB40CQ38791157-F57CD21A-B329-4D33-AF5B-7FEE1CEBE090Q39029148-29223133-F408-4F25-B971-06BE5581DB17Q42399204-DCADB66B-8A9F-4E08-89FE-A743C9828127Q47189869-8FD327E3-D01F-401B-966C-6BB2F24D10C6Q47755595-7F57D000-CC25-4D90-9B8D-825D69A68263Q49967066-8448FACF-CC75-42BE-BA85-0342BAC0AA94Q51023401-BC4077A8-EBE2-4328-8B81-B4DF9B200F44Q51734245-D66FF6D3-D027-4538-A331-2B6F54405B78Q51740148-F0730235-6289-4657-A72C-4FA6080DFB49Q51743308-1C23A40F-6A9F-4B9B-A19C-24AA3FF44682Q52720067-444D066D-8A34-4753-B3C7-27D4E4C53FCD
P2860
MicroRNA in late lung development and bronchopulmonary dysplasia: the need to demonstrate causality
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
MicroRNA in late lung developm ...... need to demonstrate causality
@ast
MicroRNA in late lung developm ...... need to demonstrate causality
@en
MicroRNA in late lung developm ...... need to demonstrate causality
@nl
type
label
MicroRNA in late lung developm ...... need to demonstrate causality
@ast
MicroRNA in late lung developm ...... need to demonstrate causality
@en
MicroRNA in late lung developm ...... need to demonstrate causality
@nl
prefLabel
MicroRNA in late lung developm ...... need to demonstrate causality
@ast
MicroRNA in late lung developm ...... need to demonstrate causality
@en
MicroRNA in late lung developm ...... need to demonstrate causality
@nl
P2860
P3181
P1476
MicroRNA in late lung developm ...... need to demonstrate causality
@en
P2093
Claudio Nardiello
P2860
P2888
P3181
P356
10.1186/S40348-016-0047-5
P407
P50
P577
2016-12-01T00:00:00Z
P6179
1020886974